Jonathan P Lai

US Patent:

20080154789, Jun 26, 2008

Filed:

Sep 6, 2007

Appl. No.:

11/851297

Inventors:

Jonathan Lai - New York NY, US
Jeong Gu Lee - Guttenberg NJ, US

Assignee:

Lehman Brothers Inc. - New York NY

International Classification:

G06Q 40/00
G06F 17/10

US Classification:

705 36 R

Abstract:

A Single Tranche Synthetic ABS product is designed to replicate economics returns of structured finance collateralized debt obligations (SF CDO) securities and allow parties to express a leveraged and/or correlation view on a custom ABS portfolio by transferring a credit risk of a particular transacted tranche of a portfolio in swap format. The inventions described herein account for an available funds cap risk of the ABS securities within the underlying portfolio in a manner equivalent to a cash analog based on the same underlying portfolio with sequential pay structure.

US Patent:

20100280970, Nov 4, 2010

Filed:

Jul 7, 2010

Appl. No.:

12/831414

Inventors:

Jonathan LAI - New York NY, US
Jeong Gu LEE - Guttenberg NJ, US

Assignee:

BARCLAYS CAPITAL INC. - New York NY

International Classification:

G06Q 40/00

US Classification:

705 36 R

Abstract:

A Single Tranche Synthetic ABS product is designed to replicate economics returns of structured finance collateralized debt obligations (SF CDO) securities and allow parties to express a leveraged and/or correlation view on a custom ABS portfolio by transferring a credit risk of a particular transacted tranche of a portfolio in swap format. The inventions described herein account for an available funds cap risk of the ABS securities within the underlying portfolio in a manner equivalent to a cash analog based on the same underlying portfolio with sequential pay structure.

US Patent:

20100325066, Dec 23, 2010

Filed:

Jul 7, 2010

Appl. No.:

12/831423

Inventors:

Jonathan LAI - New York NY, US
Jeong Gu LEE - Guttenberg NJ, US

Assignee:

BARCLAYS CAPITAL INC. - New York NY

International Classification:

G06Q 40/00

US Classification:

705 36 R

Abstract:

A Single Tranche Synthetic ABS product is designed to replicate economics returns of structured finance collateralized debt obligations (SF CDO) securities and allow parties to express a leveraged and/or correlation view on a custom ABS portfolio by transferring a credit risk of a particular transacted tranche of a portfolio in swap format. The inventions described herein account for an available funds cap risk of the ABS securities within the underlying portfolio in a manner equivalent to a cash analog based on the same underlying portfolio with sequential pay structure.

US Patent:

20130281317, Oct 24, 2013

Filed:

Nov 23, 2011

Appl. No.:

13/885203

Inventors:

Jonathan R. Lai - Bronx NY, US
Alex Stewart - New York NY, US

Assignee:

Allbert Einstein College of Medicine of Yeshiva University - Bronx NY

International Classification:

G01N 33/68

US Classification:

506 9, 536 231, 435 5, 5303875

Abstract:

Nucleic acid constructs for expressing an antibody on the surface of bacteriophage are disclosed, as are methods for using the constructs to identify antibodies that target glycans.

US Patent:

20220372079, Nov 24, 2022

Filed:

Jun 24, 2020

Appl. No.:

17/621513

Inventors:

Jonathan R. Lai - Dobbs Ferry NY, US
Julia Frei - Brugg, CH
Olivia Vergnolle - Jackson Heights NY, US
Elisabeth Nyakatura - Jersey City NY, US
George Georgiev - Bronx NY, US
Ariel Wirchnianski - Bronx NY, US

International Classification:

C07K 14/005
C12N 7/00
A61K 39/12
A61P 31/14

Abstract:

Specific resurfaced Dengue virus glycoprotein subunit E DIII variants and their uses in preventing and treating Dengue virus infection are disclosed. Provided herein are specific resurfaced Zika virus glycoprotein subunit E DIII variants and their uses in preventing and treating Zika virus infection. Multivalent vaccines comprising such resurfaced EDIII variants are also described, in addition to nanoparticle conjugated resurfaced EDIII variants.

US Patent:

20230000979, Jan 5, 2023

Filed:

May 31, 2022

Appl. No.:

17/829164

Inventors:

- Bronx NY, US
- Lebanon NH, US
- San Diego CA, US
- Austin TX, US
- Frederick MD, US
Kartik Chandran - Bronx NY, US
Jens Maximilian Fels - Bronx NY, US
Dafna Abelson - San Diego CA, US
Jason Scott McLellan - Austin TX, US
Jonathan R. Lai - Bronx NY, US
Ariel Wirchnianski - Bronx NY, US
Olivia Vergnolle - Bronx NY, US
John M. Dye - Frederick MD, US
Andrew S. Herbert - Frederick MD, US

International Classification:

A61K 39/42
A61K 45/06
A61P 31/14
C07K 16/10

Abstract:

Anti-CCHFV antibodies with neutralizing potency and protective efficacy against CCHFV are provided, as well as methods for their identification, isolation, generation, and methods for their preparation and use are provided.

US Patent:

20210163578, Jun 3, 2021

Filed:

Apr 12, 2019

Appl. No.:

17/047256

Inventors:

- Bronx NY, US
Jonathan Lai - Dobbs Ferry NY, US
Elise Ishida - Aiea HI, US
Daniel Hofmann - Moembris, DE
Tingting Chen - Bronx NY, US

International Classification:

C07K 16/12
A61P 31/06
G01N 33/569

Abstract:

Provided are high affinity capsule-specific antibodies and fragments thereof, as well as methods of use and devices employing such antibodies and/or fragments.

US Patent:

20210130443, May 6, 2021

Filed:

Dec 15, 2020

Appl. No.:

17/247532

Inventors:

- Bronx NY, US
Jonathan Lai - Dobbs Ferry NY, US
Elise Ishida - Aiea HI, US
Daniel Hofmann - Moembris, DE
Tingting Chen - Bronx NY, US

International Classification:

C07K 16/12
G01N 33/569

Abstract:

Provided are high affinity capsule-specific antibodies and fragments thereof, as well as methods of use and devices employing such antibodies and/or fragments.

Address:

264 Penns Way, Basking Ridge, NJ 07920

VIN:

1N4BL24E18C141399

Make:

NISSAN

Model:

ALTIMA

Year:

2008